In Langendorff-perfused rat hearts, the perfusion pressure was reduced from 100 cm H 2 O to 20 cm H2O for 30 minutes to produce a model of global ischemia with a residual oxygen uptake. The release of lactate dehydrogenase (LDH) and the occurrence of ventricular arrhythmias during reperfusion were dependent on the substrate. Glucose-perfused hearts had the highest rates of glycolytic ATP production (2.5 /unol/g per min) during ischemia with normal contents of tissue cyclic adenosine 3',5'-monophosphate (cAMP) and, during reperfusion, the release of LDH was lowest and severe ventricular arrhythmias did not occur. In pyruvate-perfused hearts, glycolysis was inhibited during ischemia, the rate of production of glycolytic ATP was only 0.5 junol/g per min. and tissue cAMP doubled; during reperfusion, LDH release was 14-fold higher and ventricular arrhythmias were more severe. Total tissue contents of ATP and phosphocreatine were similar in glucose-and in pyruvateperfused hearts. In hearts perfused with acetate, there was virtually no glycolytic ATP synthesized during the last 5 minutes of ischemia and cAMP increased further. Acetate-and palmitate-perfused hearts showed greatest release of LDH and had severest arrhythmias during reperfusion, suggesting that it was the metabolic and not the detergent effects of palmitate that were operating. Lipolysis was not a major factor in the cause of reperfusion LDH release. A role of glycolytic ATP in the maintenance of membrane integrity is postulated.
IT HAS BEEN postulated that circulating substrates could influence the outcome of acute myocardial ischemia by metabolic effects, with glucose and free fatty acids (FFA) exerting opposite effects. 1 There is substantial evidence that glucose in combination with insulin and potassium (GIK) exerts a beneficial effect on the outcome of regional ischemia produced by coronary artery occlusions, 1 ' 2 and some workers have suggested that increased anaerobic ATP production might be responsible for the improvement. 2 However, Rovetto et al. 3 found that lactate production during ischemia inhibited the glycolytic rate, and Opie et al. 4 found no increase in lactate in ischemic tissue during the administration of GIK to baboons. Furthermore, the major fate of glucose in ischemic tissue was oxidative metabolism. 5 Thus another possibility was that the beneficial effects of glucose in ischemia were due to increased entry of pyruvate into the citrate cycle. Exogenous pyruvate decreased ischemic effects in the pig heart, 6 while dichloracetate, an activator of pyruvate dehydrogenase, diminished ischemic damage after coronary ligation. 7 de Leiris et al. 8 using coronary artery-ligated working rat hearts, demonstrated the striking difference between substrates-fatty acids and glucose-on the severity of ischemic damage as assessed by enzyme release and confirmed by electromicroscopic studies. 9 Similar substratedependent effects on enzyme release could be expected from whole heart ischemia. In the present study we used a model of underperfusion followed by reperfusion to assess the relative roles of (1) glycolysis, by substituting pyruvate for glucose as substrate and (2) the postulated "toxic" detergent action of unbound FFA 10 on reperfusion arrhythmias and enzyme release. The effects of palmitate were compared with those of acetate which is a fatty acid homologue without detergent properties. Tissue metabolites were measured to help evaluate the processes of energy production in relation to LDH release and to arrhythmias.
Methods

Materials
Wistar or Long-Evans rats (200-380 g), fed ad libitum, were anesthetized with ether and given 200 U of heparin, iv. Hearts were perfused by the method of Langendorff for a 15-minute stabilization period to wash out enzymes released from freshly excised hearts. 11 Thereafter, hearts were perfused for a further 70 minutes in either a dripthrough or recirculation system, using the same substrates throughout except that the reperfusion buffer sometimes was changed.
The perfusion fluid was Krebs-Henseleit bicarbonate SUBSTRATES, LDH RELEASE, AND ARRHYTHMIAS/Brjc/ene/Z and Opie 103 buffer, pH 7.4, 37°C, gassed with 95% O 2 :5% CO 2 or with 95% N 2 :5% CO 2 . Oxygen tension in the perfusate and coronary effluent was measured by a Radiometer macroelectrode (type PHMM1). Substrates used were 11.1 IDM glucose (Analar, Hopkins and Williams), 5 mM sodium pyruvate (Miles-Seravac, or Boehringer Mannheim), 3.6 mM sodium acetate (Analar; British Drug Houses), or the potassium salt of 0.5 mM palmitic acid (British Drug Houses), conjugated to 0.1 mM bovine albumin fraction V (Miles-Seravac or Nutritional Biochemicals). Dialyzed albumin solutions were split for the addition of glucose and/or palmitate.
Protocol
The 70-minute perfusion period was divided into three phases: (1) from 0 to 10 minutes, referred to as the preischemic control period; (2) from 10 to 40 minutes, the ischemic period, and (3) from 40 to 70 minutes, the reperfusion period. In control experiments perfusion pressure was maintained at 100 cm H 2 O throughout the 70minute experimental period, but in all other studies the second phase or ischemic period perfusion pressure was reduced from 100 to 20 cm, and on the termination of this period, the hearts were reperfused at a perfusion pressure of 100 cm H 2 O for the last 30 minutes.
Model of Ischemia
By reducing the perfusion pressure by 80% from 100 cm H 2 O to 20 cm H 2 O, the coronary flow was rapidly reduced by 85.5 ± 0.7% (mean ± SEM) (n = 35) within the first 5 minutes. Thereafter, changes in coronary flow were dependent on the available substrate. Simultaneous with the reduction in coronary flow, within 5 minutes there was a decrease of 75 ± 2% (n = 9) in left ventricular (LV) systolic pressure. Oxygen uptake decreased by about 75-85% (see later). Hearts perfused at 20 cm H 2 O manifested features similar to those in other models of ischemia: 12 (1) reduced contractile activity, (2) impaired initiation and conduction of electrical impulse (see Table  1 ), (3) "reactive hyperemia," a sign of previous underperfusion ( Fig. 1 ), (4) decreased contents of high-energy phosphate compounds (see Table 2 ), and (5) increased lactate output (Fig. 3) .
The presence of ischemia also was shown by reduced heart rates (Table 3 ). In the ischemic period, the heart rate decreased, with lower rates reached for acetate and palmitate than for glucose; pyruvate values lay between those for glucose and acetate. During reperfusion, glucose-and pyruvate-perfused hearts rapidly regained control heart rates but acetate and palmitate hearts were slower (P < 0.001). During experiments with a perfusion pressure of 100 cm H 2 O throughout, heart rates were stable.
Ischemia is by definition a lack of arterial blood flow, 12 but isolated hearts perfused with oxygenated nutrient buffers have been described as ischemic when the flow of these buffers through the coronary bed is either artificially reduced 3 or completely stopped. 13 For convenience, the period of reduced pressure in our model will be referred to as the ischemic period.
Contractile Activity and Arrhythmias
Measurement of LV pressure necessitates piercing the muscle wall with the catheter which could induce enzyme release; hence aortic pressure was measured. Aortic pressure pulses diminished during underperfusion and ceased during ischemic arrest. To assess whether hearts arrested in a contracted or relaxed state, a Grass model FT 03C force displacement transducer was attached to the apex. The electrocardiogram (ECG) and aortic pressure were recorded by a dual channel model M2 Devices Instrument, or a Grass Polygraph model 79D. The ECG electrodes were attached to the apex and to the metal aortic cannula.
To quantify more precisely the arrhythmias induced on reperfusion, bipolar electrodes were hooked into the right atrium and the left ventricle. The number of contractions due to ectopics of ventricular origin were counted per minute and expressed as a percentage of the total number of contractions for that minute or, in the case of transient ventricular fibrillation, its duration as percentage of a minute.
Biochemical Analyses
Lactate dehydrogenase (LDH) in the perfusate was measured by the method of Wroblewski and La Due 14 and expressed as milliunits per gram wet weight per minute at 25°C. In recirculation experiments, the residual LDH in the perfusate from the previous period was subtracted in each case. The concentration of freshly released LDH did not degrade appreciably in the apparatus. A comparison of results from the recirculation and the drip-through perfusions showed no significant difference; results were pooled.
Perfusate lactate, pyruvate, and glucose were determined enzymaticalry. 15 For tissue analysis, hearts were freeze-clamped either at the end of the initial 10-minute period or at the end of the 30-minute ischemic period. The tissue was extracted in cold perchloric acid and analyzed for ATP, phosphocreatine, inorganic phosphate, glycogen, citrate, a-glycerophosphate, lactate, and the dry weight-wet weight ratio. 16 Metabolic values are expressed in terms of fresh weight (= dry weight X5; see Opie et al. 16 cAMP was measured by the Radiochemical Centre cAMP assay kit, code TRK 432.
Statistical Procedures Used
Results are expressed as mean values ± standard error of the mean (SEM) for the number of observations, with P values derived from either the conventional Student's i-test allowing for unequal variances or from the variance ratio F-test, or 2 X C contingency tables. 17 In cases in which the standard deviations were proportional to the means, a log transformation was used in the figures. 18
Results
Effects of Ischemia and Reperfusion on Heart Rhythm (Tables 1 and 3)
Although the arrhythmias' recorded during the ischemic period were largely supraventricular in origin, the s 1.79 ± 0.15 (6) 0.273 ± 0.037 (10) 0.203 ± 0.046 (6) 0.33 ± 0.01 (8) 0.074 ± 0.006$ (7) 0.46 ± 0.04 (6) 0.60 ± 0.05 (6) 0.120 ± 0.020 (6) 0.055 ± 0.021 A (6) 0.055 ± 0.013 (12) 0.382 ± 0.074 A (6) 0.048 ± 0.004 (8) 0.040 ±0.016 (6) 0.034 ± 0.011 (10) 0.880 ± 0.067$ (6) 0.13 ± 0.04 (8) 1.01 ± 0.08$ (7) 0.015 ± 0.009 (6) 0.020 ± 0.009 (6) 0.26 ± 0.08 Units: jumol/g fresh heart weight: glycogen as jumol glucose equivalent. Numbers in parentheses indicate number of hearts. Abbreviations: rtGP = a-glycerophosphate; ATP = adenosine triphosphate; PCr = phosphocreatine; Pj = inorganic phosphate; C = control (heart freeze-clamped after 10 minutes with control perfusion pressure of 100 cmHjO); I «= ischemic (heart freeze-clamped after 30 minutes of ischemia, i.e., perfusion pressure of 20 cm H 2 O).
* Glycogen content of acetate hearts after 25 minutes of ischemia was 4.73 ±1.18 (9) . f For importance of FFA-albumin molar ratio in the rate of FFA uptake and FFA metabolism (see Willebrands et al. 21 ). § If the control perfusion is continued for 70 minutes, tissue values were: ATP = 3.82 ± 0.06 (7) ; PCr = 5.21 + 0.15 (9); glycogen = 14.0 ± 1.6 (7) . A = P < 0.05 cf. control; A = P < 0.005 cf control; $ = P < 0.001 cf. control. arrhythmias generated on reperfusion 19 were mainly ventricular, and the incidence of serious types such as ventricular tachycardia and ventricular fibrillation was substrate dependent, being higher in hearts perfused with palmitate than with glucose. For glucose-and acetate-perfused hearts, the incidence of ventricular ectopic activity also differed ( Fig. 3 ). Ventricular ectopic beats (VPB) were identified by their QRS morphology but, because of the rapid heart rate, some atrioventricular (AV) junctional beats could have been included. The peak incidence of VPB in glucose-perfused hearts was less than 5% in the first minute of reperfusion, whereas the corresponding acetate rate was nearly 95% (P < 0.001; Fig. 3 ). VPB in glucose-perfused hearts stopped after 2 minutes of reperfusion but still occurred over the next 9 minutes in acetate-perfused hearts. Thus, reperfusion arrhythmias do not depend on the nonspecific detergent action of FFA, and glucose protects in a better way than pyruvate.
Pattern of LDH Release during the Three Phases of the Experimental Protocol (Table 4)
During ischemia there was little difference in the rates of release of LDH for all the substrates tested, but major differences became apparent on reperfusion 20 (Table 4B) , when highest rates of LDH release were found in acetateand in palmitate-perfused hearts, with lower values for pyruvate-and lowest values in glucose-perfused hearts. Hearts perfused with lactate or without substrate had values between those of pyruvate and acetate.
The opposing effects of glucose and free fatty acid on the acutely ischemic myocardium 1 were investigated by posing the following questions: (1) whether the observed difference between palmitate and glucose was due to the beneficial effect of anaerobic glycolysis by providing ATP near the cell membrane (see later) or (2) whether the major difference between glucose-and palmitate-induced LDH release was solely due to the nonspecific detergent action of unbound fatty acids on cell membrane lipids. 10 
' 21
The Influence of Glycolysis: Glucose vs. Pyruvate
One of the end-products of the glycolytic pathway, pyruvate, is utilized readily by the heart as a fuel and inhibits glycolysis. 22 The reperfusion release of LDH was 14-fold greater when pyruvate was substituted for glucose, indicating that glycolysis plays an important role in the prevention of enzyme release. Because the rate of enzyme release during reperfusion with pyruvate was lower than with palmitate, a further mechanism could be operative.
Specific Effects of Fatty acids: Palmitate vs. Acetate
Peifusion with acetate, which is a readily metabolized homologue of palmitate without detergent properties, was Lactate production from glucose-, pyruvate-, or acetate-perfused hearts for the 10-minute control period (perfusion pressure = 100 cm H^O) and the 30-minute ischemic period (pressure = 20 cm H2O) is shown. In glucose-perfused hearts (O) lactate is formed from both glycogenolysis and glucose uptake; in pyruvate-perfused hearts (A) the source of lactate is from glycogenolysis and the reduction of some of the pyruvate uptake. Measurements of tissue glycogen and the plot of lactate output minus pyruvate uptake being consistently negative, both show that glycogenolysis made a minor contribution to lactate production in pyruvate hearts. In acetate-perfused hearts (9) , the only source of lactate is glycogenolysis. LAC. = lactate; PYR. = pyruvate. However, in control nonischemic perfusions, palmitateperfused hearts had consistently higher rates of release of LDH than did acetate-perfused hearts, and the content of phosphocreatine fell (P < 0.005); similarly, during the ischemic period, there were lower levels of phosphocrea-
The number of contractions due to ectopics of ventricular origin were counted per minute and expressed as a percentage of the total number of contractions for that minute or, in the case of transient ventricular fibrillation, its duration as percentage of a minute. No ectopic activity was recorded either during the 10-minute control period or the 30-minute ischemic period. Arrhythmias commenced from the onset of reperfusion at 40 minutes, and the increased ectopic activity during the first minute in acetate hearts was highly significant (P «sc 0.001). Mean values ± SEM; n = 4. tine (P < 0.025) and of glycogen (P < 0.05) in palmitatethan in acetate-perfused hearts. These data suggest a small specific effect of fatty acids in enhancing metabolic damage. Table 4 shows that, during reperfusion, the rates of LDH release for acetate-perfused hearts are greater than for pyruvate-perfused hearts, but not different from palmitate-perfused hearts. Thus the nonspecific detergent action of palmitate is not the major mechanism of free fatty acid toxicity in the reperfusion phase in our model.
Role of Endogenous Lipolysis
The possibility that the increased rates of LDH release from hearts perfused with non-glucose substrates could be mediated through the accumulation of tissue free fatty acids released by endogenous lipolysis during ischemia was investigated. Stimulation of lipases occurs in ischemia. 23 Levels of tissue cAMP (Fig. 4) were high enough to stimulate the cardiac lipase system 24 both in pyruvateand in acetate-perfused hearts. Antilipolytic agents and agents that either decreased or increased the tissue cAMP were added to the perfusate buffer. Of the nine interventions (Table 5 ) used, only four were significant, although, in every case, the release of LDH with reperfusion changed in the expected direction. The persisting high rates of LDH release in hearts treated with antilipolytic agents suggests that the influence of endogenous lipolysis is not a major factor.
Deleterious Effect of Acetate Compared with Pyruvate
The rate of reperfusion release of LDH was nearly 4fold greater with acetate than with pyruvate. The deleterious effect of acetate in ischemia was unexpected since acetate is readily metabolized by the heart 25 and does not appear to have any adverse effect even in concentrations up to 10 mM. 22 effect on the ischemic heart; both caused early arrest and a rapid decrease in coronary flow. Hearts with the greatest LDH release had the severest reduction in coronary flow, became darker in color and arrested earliest, and became firm and hard to the touch, in some ways resembling the "stone heart." 26
Severity of Ischemia as a Determinant of the Reperfusion LDH Release
Functional Correlates A regression analysis comparing various parameters measured during the ischemic period with the amount of LDH released during the reperfusion period shows a number of significant correlations (Table 6 ). Both the decrease in coronary flow during the ischemic period and the duration of the ischemic arrest had high correlation coefficients (0.8 and 0.9, respectively) ( Fig. 5) . Therefore, the state of the heart at the end of the ischemic period in some manner governed the amount of LDH released on reperfusion. Hearts with the highest postischemic LDH release were in a contracted condition with low coronary perfusion suggesting that LDH lost from the cells would accumulate in interstitial spaces during the ischemic period. On reperfusion, the accumulated LDH may be washed out 13 and the resumption of contraction might worsen the already damaged cell membrane by the mechanical forces." Fig. 1 shows that the highest rate of LDH release was immediately following reperfusion; the rate subsequently declined rapidly.
Substrate during Ischemia as Opposed to Reperfusion
Hearts perfused with glucose during the preischemic control period and the ischemic period and reperfused with buffer containing acetate release only one-tenth of the LDH of those perfused throughout with acetate ( Table 4B ). Therefore, the major portion of LDH release during reperfusion was dependent on the substrate provided during ischemia.
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Influence of Oxygen during Reperfusion
Acetate hearts were reperfused with anoxic buffer for 15 minutes, and then normal oxygenation was resumed for the remaining 15 minutes (Fig. 6 ). Although the rate of LDH release was approximately 20% lower when anoxic perfusate was used during the first 15 minutes of reperfusion, it was not different from the rate of LDH release with normoxic perfusate. The time of the reintroduction of oxygen is important in initiation of the subsequent enzyme release. 27 Similar rates of LDH release with either anoxic or normoxic buffer suggest that the ischemic damage is not sufficient to precipitate the reoxygenation toxicity phenomena although the reintroduction of oxygen after a further 15 minutes of anoxia caused massive enzyme release (Fig. 6 ). Therefore, in our model, oxygen toxicity is not the major cause of reperfusion LDH release. 
Severity of Ischemia: Vascular vs. Metabolic Factors
One of the earliest manifestations of ischemic damage is the loss of regulation of cell volume 28 leading to an accumulation of tissue water and increased vascular resistance upon reintroduction of coronary flow. That changes in vascular resistance might have played an important role in our model is suggested by (1) the high correlation between the reduction in ischemic coronary flow and LDH release and (2) the failure of reactive hyperemia to develop in the acetate and no-substrate groups during reperfusion (Fig. 1) .
MINUTES of ISCHEMIC ARREST
To explore the cause of increased vascular resistance during the ischemic period, the following proposals were tested. (1) If the resistance were due to edema and swelling of myocardial cells or the capillary endothelial cells, then resistance to coronary flow would precede and cause the hypercontracted state of the ischemic heart. (2) However, if the myocardium first develops ischemic contracture due to metabolic derangements, then the compression of the vessels by the contracted muscle would result in a simultaneous increase in resistance to coronary flow and an increase in resting muscle tension. Changes in vascular resistance during ischemia were measured by perfusing the heart with a constant coronary flow and monitoring the mean aortic perfusion pressure. Muscle tension was measured by attaching a force transducer to the apex of the heart. During acetate perfusions at a coronary flow of 0.5 ml/min, the increase in resting tension of the heart occurred either before or at the same time as the rise in perfusion pressure and developed hypercontraction as shown by the diastolic tension rising above the peak systolic pressure in the preischemic control period (Fig. 7) . Thus the increased vascular resistance was due to ischemic myocardial contracture rather than a vascular factor. On the contrary, glucose-perfused hearts which developed reactive hyperemia during reperfusion did not develop contracture during the ischemic period.
Metabolic Status of the Heart before the Beginning and at End of the Ischemic Period (Table 2)
At the beginning of the ischemic period, similar values were found for ATP, phosphocreatine, inorganic phosphate, and glycogen in glucose-and in pyruvate-perfused hearts. ATP fell in acetate-perfused hearts, which were otherwise similar. However, prolonged perfusion with acetate did not further decrease the ATP value. In hearts perfused with no substrate, phosphocreatine and glycogen fell during the control period and were very low during ischemia, suggesting that such hearts were unable to maintain a proper rate of energy production. 29 The low values of ATP, phosphocreatine, and glycogen of the control hearts perfused with palmitate (0.5 HIM) was due to our choice of a "toxic" palmitate-albumin molar ratio of 5:1, 21 since changing the concentration of either albumin or palmitate to a ratio close to 2:1 markedly increased both the contents of high energy phosphate compounds and of glycogen. Thus the role of a high FFA-albumin molar ratio in fatty acid toxicity 1 is confirmed.
During the ischemic period, there were the expected The rise in diastolic muscle tension occurs before the rise in perfusion pressure. Increased mean aortic pressure during constant infusion represents an increase in vascular resistance (see text).
SUBSTRATES, LDH RELEASE, AND ARRHYTHMIAS/Bricknell and Opie
111 changes in tissue metabolites: (1) a decrease in the contents of high energy phosphates and of glycogen and (2) an increase in inorganic phosphate, lactate, and a-glycerophosphate. Acetate-or palmitate-perfused hearts had lower values of high energy phosphates and of glycogen than did glucose-or pyruvate-perfused hearts. The tissue values of ATP and phosphocreatine in pyruvate-perfused hearts were the same as in glucose-perfused hearts; yet, the LDH release was more than 10-fold greater (Fig. 8 ). This is not consistent with the hypothesis that total tissue ATP determines LDH release. 30 " 32 However, rates of glycolytic flux were different in pyruvate-and in glucoseperfused hearts.
Glycolytic Flux during Ischemia
Glycolytic flux was calculated from substrate uptake, glycogen changes and lactate production during ischemia (Tables 7 and 8 ). Comparing glucose and pyruvate, flux from glycogenolysis was similar. However, in glucoseperfused hearts, the uptake of glucose (Table 8) provided the major source (86%) of the total flux. If flux through the pentose shunt is negligible, then the average amount of ATP produced glycolytically can be estimated (See Table 8 ). By assuming the P/O ratio is 3 for both glucose and pyruvate but 2.5 for acetate, the average aerobic production of ATP can be estimated from the oxygen uptake ( Table 8 ). The total rates of ATP production are comparable for glucose and pyruvate, but the percentage of ATP produced glycolytically in the ischemic period was different, being 24% for glucose and 7% for pyruvate. In acetate-perfused hearts, glycolytic flux during ischemia was entirely dependent on glycogenolysis. Although the average glycolytic flux was higher for acetate than for pyruvate (Table 8) , contents of ATP and phosphocreatine fell to values less than half of those in pyruvate hearts. To explain this apparent contradiction, the tissue glycogen content of acetate-perfused hearts was measured 5 minutes before the end of ischemia and was no different from that at the end. The rapid decline in lactate production in acetate-perfused hearts during ischemia also shows that the rates of glycogenolysis had fallen to below pyruvate values ( Fig. 3) . Consequently, glycolytic ATP production ( Table 8) was extremely low in acetate-perfused hearts at the end of the ischemic period.
Discussion
Aerobic vs Glycolytic ATP
We describe three groups of hearts: (1) glucose-perfused hearts with a relatively high glycolytic flux, (2) pyruvate-perfused hearts with inhibited glycolysis, probably due to the high intracellular citrate content and inhibition of phosphofructokinase, 33 and (3) acetate-perfused hearts with virtual cessation of the glycolytic flux at the end of ischemia after initial stimulation. These data suggest that the rate of glycolytic flux during ischemia may prevent enzyme release during reperfusion. The ATP produced by glycolytic flux may play a special role in the maintenance of the membrane integrity and function. Functional compartmentation of ATP already has been postulated. 34 Aerobically produced ATP may supply energy for contraction, whereas glycolytically produced ATP may be linked to transmembrane electrical activity 35 and the ionic pumps. 36 ATP but not ADP is absorbed and firmly bound to the cell membrane proteins in both hearts and other excitable tissue. 37 A submembrane nondiffusible ATP pool may be supplied preferentially by strategically positioned glycolytic enzymes, 38 especially membrane-bound phosphoglyceratekinase, 36 ' 39 as in the case of erythrocytes. Gudbjarnason et al. 34 postulate an inhibition of intracellular energy transfer in ischemic muscle which might be explained by a breakdown of the unidirectional phosphocreatine energy shuttle 40 ' 41 and exaggeration of ATP compartmentation. The cardiac sarcoplasmic reticulum has associated with it a system of glycogenolytic enzymes 42 and, because this membrane is impermeable to ATP, 43 glycolysis in this organelle may be important in the control of intracellular calcium ion concentrations. Glycolytically formed ATP may be available for membrane functions such as ionic pumps and the maintenance of the phosphatidic acid cycle, thereby preventing the accumulation of lysophospholipids which are highly membrane-active and might cause cell lysis, 32 ' ** thus allowing leakage of macromolecules such as enzymes.
Speculative links between Cytoplasmic ATP Production, cAMP, and LDH Release
Another difference between the substrate groups was that the tissue cAMP rose during the ischemic period in 112 CIRCULATION RESEARCH VOL. 43, No. 1, JULY 1978 pyruvate-and especially in acetate-perfused hearts (no data available for fatty acid hearts). Furthermore, there was a remarkable correlation between tissue cAMP during ischemia and release of LDH during reperfusion (Fig.  4) . In glucose-perfused hearts, cAMP did not rise during ischemia, nor was there release of LDH during the reperfusion period. There are at least three possible explanations for the links between beneficial effects of glucose and the levels of cAMP found in the ischemic period. First, glucose-perfused hearts with the highest rates of production of glycolytic ATP are best protected against the effects of ischemia, and hence might liberate least endogenous catecholamines 23 and therefore have the lowest cAMP levels. Conversely, acetate-perfused hearts with severest ischemia would have highest cAMP levels. Second, substrate utilization could in some way control production and degradation of cAMP. In microorganisms, glucose transport across the cell membrane inhibits adenyl cyclase. 45 A third speculative but unifying hypothesis may be that entry of calcium ions could be the connecting link ( Fig. 9 ). High rates of cytoplasmic ATP production may be required for optimal function of the membrane ion pumps (see above). Hypoxic damage and depletion of cytoplasmic ATP could allow greater ingress of sodium and calcium ions 46 as would accumulation of cAMP. 47 Hearts with greater accumulation of calcium ions would exhibit an increased diastolic tension and would arrest earlier in contraction (as in acetate hearts) and this would result in lower coronary flows in the ischemic period (as in acetate hearts) and would also limit reactive hyperemia and the heart rate in the reperfusion period (as in acetate hearts).
As a consequence of increased intracellular ionized Numbers in parentheses indicate number of hearts. * Assuming no oxygen wastage, no uncoupling, and the theoretical P/0 ratio for each substrate. tThe source of the glycolytic flux in glucose hearts is from both glucose uptake (1.01 jimol/g per min) and glycogen breakdown (0.16 jimol glucose equivalents/g per min.) For the other substrates the source is glycogenolysis. Glycolytic ATP production is calculated as 2 ATP derived from each glucose molecule used and 3 ATP per glucose equivalent from glycogen breakdown. Total ATP production is the sum of aerobic and glycolytic ATP production. 2) inhibited with pyruvate as substrate, and (3) first increased, then decreased with acetate. The modulation of LDH release by nicotinic acid, insulin, andpropranolol in pyruvate-perfused hearts could be mediated through lipolysis (e) by causing the accumulation of acyl-CoA which inhibits adenine nucleotide translocase. The depletion of glycogen in acetate-and palmitateperfused hearts could be by cAMP-mediated glycogenolysis (f). Both the limitation of glycolytic ATP and the increase in cAMP could allow a rise (g and h) in free intracellular calcium. Increased free Ca 2 *, as evidenced by ischemic contracture (j), could further reduce ATP by calcium overload (i). Hypercontraction of the heart (k), as in the case of acetate-and palmitateperfused hearts, could further exaggerate ischemia by (1) the reduction of small vessel perfusion. Enzyme washout on reperfusion (m) would, therefore, reflect severity of the ischemic process. calcium, two vicious circles could be created ( Fig. 9 ): (1) greater ATP demand 48 and respiratory accumulation of calcium by the mitochondria may occur at the expense of phosphorylation, 49 ' M and (2) the hypercontracted state could reduce coronary perfusion of the small vessels leading to more severe ischemia. 51 Global ischemia is not homogeneous, 52 and some intercapillary areas are more vulnerable to anoxia. 53 Therefore, substrates may have variable effects in various areas, even in global ischemia.
SUBSTRATES, LDH RELEASE, AND ARRHYTHMIAS/BrtcMeZ/ and Opie
Substrates and Arrhythmias
Possible links between substrate supply and the development of reperfusion arrhythmias in non-glucose-perfused hearts are as follows. First, the increased content of cAMP at the end of the ischemic period in the case of non-glucose substrates could stimulate endogenous lipolysis; the rate of lipolysis has been linked to arrhythmogenesis by Oliver and his group. 10 However, pyruvate-perfused hearts developed more arrhythmias than did glucose-perfused hearts, but inhibition of endogenous lipolysis (Table 1) by nicotinic acid at 10~7 M 24 did not reduce reperfusion arrhythmias in pyruvate-perfused hearts. Second, Podzuweit and co-workers 54 have proposed a special role for cAMP in promoting arrhythmias by producing slow channels in ischemia which could provide an explanation for an association between cAMP and reperfusion arrhythmias (Podzuweit and Phillips, unpublished observation). Alternatively, cAMP-induced high intracellular calcium 55 could uncouple intercellular electrical continuity, resulting in ventricular fibrillation. 56 Increased cardiac vulnerability to ventricular fibrillation can be induced by dibutyryl cAMP. 57 Third, rates of formation of cytoplasmic ATP by glycolysis may play a role in the maintenance of the duration of the normal action potential 35 -46 and hence in the prevention of arrhythmias. A protective effect of glucose on the development of ventricular tachycardia 58 or fibrillation 59 has been shown for dog hearts with coronary occlusion. Willebrands et al. 60 found that glucose but not pyruvate reduced the incidence of ventricular arrhythmias during and after oxygen restriction in isolated rat hearts.
Relevance to Other Models
Our model differs from both the regional ischemic model of Opie 5 and the globally ischemic isolated rat heart model of Neely and co-workers 3 because rates of anaerobic ATP production in this model are high relative to those of aerobic ATP. Furthermore, during ischemia, rates of glucose uptake were maintained rather than decreased as in Neely's model, probably because the reduction of coronary flow was not as severe 61 and the work load was diminished in our model. The lactate values reached in our glucose-perfused hearts were low and did not approach those reported to inhibit glycolysis at the level of glyceraldehyde phosphate dehydrogenase. 62 Liedtke et al. 6 who found an improvement in pig hearts subjected to global ischemia when infused with pyruvate plus Tris buffer, suggested that the lactate inhibition of ischemic glycolysis could be reversed by this treatment. However, they also found decreased palmitate oxidation during administration of pyruvate-Tris. In the present model, 5 mM pyruvate was found to inhibit glycolysis during ischemia. Our hearts were given only one substrate per experiment, and pyruvate had a greater protective effect against ischemia than did palmitate. Hence the results of Liedtke et al. 6 could be explained in part by promotion of pyruvate metabolism at the expense of free fatty acid oxidation.
